U.S. Markets open in 24 hrs, 15 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 20.61 10:21 AM EST | |
|---|---|---|
| Day High | 21.02 09:42 AM EST |
|
| Range | 0.41 |
| Volume | 496,243 | |
|---|---|---|
| 30-Day Avg Vol | 759,000 |
|
| Difference | -34.62% |
| Market Cap | 1.02 B | |
|---|---|---|
| Mkt Cap Chg | -6.83 M |
| Shares Out | 48.82 M | |
|---|---|---|
| % Shrs Traded | 1.02% | |
| 1yr EPS Est | -0.353 |
| 52-Wk Low | 6.14 | |
|---|---|---|
| 52-Wk High | 24.23 |
|
| Range | 18.09 |
| Prev Close | 21.08 11/5/09 | |
|---|---|---|
| Today's Open | 20.85 | |
| Change | -1.09% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 4.5 M |
| Revenue (LFY) | 178.76 M | |
|---|---|---|
| Earnings (LFY) | -47.04 M | |
| Earnings (MRQ) | -15.32 M | |
| Next Earn Est | -0.287 | |
| Next Earnings | 03/08/2010 |
|
| EPS (TTM) | -0.94 | |
| 1yr EPS Growth | 62.45% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -59.00 | |
| PEG Ratio | -1.36 | |
| Return on Equity | -17.22 | |
| Beta | 0.79 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Salix Pharmaceuticals is a finishing school for tummy drugs. Focusing on drugs for gastrointestinal diseases, the company shops for drug candidates nearing commercial viability. It then takes them through ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.287 11/9/09 | — — |
—
—
|
| Last Quarter | -0.351 6/30/09 | -0.32 6/30/09 |
0.031
Beat
|
| 2 Quarters Ago | -0.372 3/31/09 | -0.29 3/31/09 |
0.082
Beat
|
| Quarterly - 06/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 52.23 M | 178.77 M |
| Gross Profit | 38.32 M | 125.06 M |
| Operating Income | -14.01 M | -46.66 M |
| Net Income | -15.32 M | -47.04 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts